TrialEpilepsia open2024

Phosphatidylserine enriched with polyunsaturated n-3 fatty acid supplementation for attention-deficit hyperactivity disorder in children and adolescents with epilepsy: A randomized placebo-controlled trial.

Sylvain Rheims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.